Considering your experience with Sharlife so far, how likely are you to recommend us to a friend or colleague?
Not at all likelyExtremely likely
(Optional)
Vertex Pharmaceuticals Incorporated
VRTXHealth technology
$110.9B
Market Cap
Shariah Analysis
Failed
Business
Cash
Liabilities
Based on AAOIFI screening standards, Vertex Pharmaceuticals Incorporated appears to be Failed.
Business Activity
FYE 2024
Non-Permissible Income (<5%)5.10%
Non-Permissible
$598
Total Income
$11.6K
Revenue Breakdown
TRIKAFTA/KAFTRIO
$10.2K
Other product revenues
$782
Interest income
Non-Operating
$598
Non-Compliant: $598
Change in fair value of contingent consideration
Non-Operating
$0
Financial Screening
FYE 2024
Cash (<30%)6.04%
Non-Shariah Cash Items
Cash And Cash Equivalents$4.6B
Other Short Term Investments$1.5B
Hedging Assets Current$130.1M
Liabilities (<30%)1.69%
Non-Shariah Liabilities
Current Capital Lease Obligation$92.3M
Long Term Capital Lease Obligation$1.7B
Market Data
Exchange
NASDAQ
CurrencyUSD
CountryUnited States
Last Updated2026-01-09
Disclaimer: Shariah screening is based on the latest available financial data. Market conditions and company activities may change. Always conduct your own due diligence.
NASDAQ
